The global somatostatin analogs market is witnessing steady growth and is positioned to expand significantly in the coming years. Valued at USD 7.79 billion in 2023, the market is estimated to grow to USD 8.25 billion in 2024 and is further projected to reach USD 13.17 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.90 percent during the forecast period.
This growth...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά